Abstract
We present Moldrug, a computational tool for accelerating the hit-to-lead phase in structure-based drug design. Moldrug explores the chemical space using structural
modifications suggested by the CReM library and by optimizing an adaptable fitness function with a genetic algorithm. Moldrug is complemented by Moldrug-Dashboard, a cross-platform and user-friendly graphical interface tailored for the analysis of Moldrug simulations. To illustrate Moldrug, we designed new potential inhibitors targeting the main protease (MPro) of SARS-CoV-2 by optimizing a consensus fitness function that balances binding affinity, drug-likeness, and synthetic accessibility. The designed molecules exhibited high chemical diversity. A subset of the designed molecules were ranked using MM/GBSA and alchemical binding free energy calculations, revealing predicted affinities as low as −10 kcal mol−1. Moldrug is distributed as a Python package under the Apache 2.0 license. It offers pre-configured multi-parameter fitness functions for molecular design, while being highly adaptable for integrating functionalities from external software. Documentation and tutorials are available at https://moldrug.rtfd.io.
Supplementary materials
Title
Moldrug algorithm for an automated ligand binding site exploration by 3D aware molecular enumerations
Description
SI for the working paper
Actions
Supplementary weblinks
Title
Moldrug algorithm for an automated ligand binding site exploration by 3D aware molecular enumerations
Description
Link to the repository and tutorials of Moldrug algorithm
Actions
View